Latest Articles

Publication Date
Bindi Irwin Shares Diagnosis That Took 10 Years to Find: ‘Inescapable Pain’ - Newsweek

Bindi Irwin Shares Diagnosis That Took 10 Years to Find: ‘Inescapable Pain’ Newsweek

Published: April 3, 2026, 12:30 a.m.
Bindi Irwin Shares Diagnosis That Took 10 Years to Find: ‘Inescapable Pain’ - newsweek.com

Bindi Irwin Shares Diagnosis That Took 10 Years to Find: ‘Inescapable Pain’ newsweek.com

Published: April 3, 2026, 12:30 a.m.
Major postoperative complications after endometriosis surgery: incidence and outcomes from a multicenter French cohort.

Surgery is a therapeutic option for patients with deep endometriosis presenting with infertility and/or pain refractory to medical treatment. Major postoperative complications may impair quality of life and delay the …

Published: April 3, 2026, midnight
Soap star reveals crippling health diagnosis after years of painful symptoms - The Irish Sun

Soap star reveals crippling health diagnosis after years of painful symptoms The Irish Sun

Published: April 2, 2026, 10:02 a.m.
Soap star reveals crippling health diagnosis after years of painful symptoms - thesun.ie

Soap star reveals crippling health diagnosis after years of painful symptoms thesun.ie

Published: April 2, 2026, 10:02 a.m.
Bindi Irwin speaks out on 'indescribable pain' from 'invisible disease' in heartbreaking health update - Newsner

Bindi Irwin speaks out on 'indescribable pain' from 'invisible disease' in heartbreaking health update Newsner

Published: April 2, 2026, 8:20 a.m.
Governments call on general practice for pelvic pain help - Medical Republic

Governments call on general practice for pelvic pain help Medical Republic

Published: April 2, 2026, 4:42 a.m.
Governments call on general practice for pelvic pain help - medicalrepublic.com.au

Governments call on general practice for pelvic pain help medicalrepublic.com.au

Published: April 2, 2026, 4:42 a.m.
My “Normal” Pain: A Surgeon’s Impossible Choice - patrolmedia.co.id

My “Normal” Pain: A Surgeon’s Impossible Choice patrolmedia.co.id

Published: April 2, 2026, 12:38 a.m.
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.

Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …

Published: April 2, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!